France is the leading European country in innovative payment schemes supporting evidence generation or early adoption of medical technologies. One of the schemes is Transitional Coverage of Medical Devices, which provides temporary reimbursement of devices used in inpatient or home care settings before applying for registration in the List of Reimbursable Products and Services (LPPR) for regular reimbursement.
Our latest White Paper provides a comprehensive exploration of this pivotal scheme. It unpacks the strategic rationale, administrative process, and eligibility requirements – offering clarity on how manufacturers are leveraging this mechanism to accelerate adoption of novel technologies in inpatient and home care settings.
Through a detailed case study of the FlowTriever System, this document reveals how select innovators have succeeded in navigating the Transitional Coverage framework, what set them apart from unsuccessful applicants, and what happens when promising technologies fall short of HAS expectations during reassessment.
This report is designed to help medical device manufacturers, market access professionals, and health policy leaders understand the evolving landscape of innovation funding in France. With early access increasingly tied to evidence generation, understanding the mechanics of schemes like Transitional Coverage is essential for successful market entry and sustained reimbursement.
Request White Paper
Request analytical White Paper and advance your understanding of European market access for medical devices